Dr. Beltran earned her medical degree from Harvard Medical School and completed her residency at MD Anderson Cancer Center. Board-certified in Medical Oncology, Hematology, and Internal Medicine, she has authored over 150 publications that have contributed to the understanding of prostate cancer biology and treatment resistance. Her research focuses on neuroendocrine differentiation pathways and the development of targeted therapies to overcome therapeutic resistance. Dr. Beltran has been recognized with awards from ASCO, AACR, and the Prostate Cancer Foundation for her innovative research and dedication to patient care. She is passionate about mentoring graduate students and postdoctoral researchers, fostering an environment of scientific excellence at Weill Cornell Medicine.
Dr. Himisha Beltran is a rising star in medical oncology at Weill Cornell Medicine, specializing in the neuroendocrine differentiation of prostate cancer. Her clinical practice focuses on translating cutting-edge research into effective treatments for patients with advanced prostate cancer. Dr. Beltran leads translational research studies aimed at identifying novel biomarkers and therapeutic targets, enhancing personalized treatment approaches and improving patient outcomes.
Dr. Beltran earned her medical degree from Harvard Medical School and completed her residency at MD Anderson Cancer Center. Board-certified in Medical Oncology, Hematology, and Internal Medicine, she has authored over 150 publications that have contributed to the understanding of prostate cancer biology and treatment resistance. Her research focuses on neuroendocrine differentiation pathways and the development of targeted therapies to overcome therapeutic resistance. Dr. Beltran has been recognized with awards from ASCO, AACR, and the Prostate Cancer Foundation for her innovative research and dedication to patient care. She is passionate about mentoring graduate students and postdoctoral researchers, fostering an environment of scientific excellence at Weill Cornell Medicine.